Drug name - Zubsolv

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8658198 OREXO US INC Non-abusable pharmaceutical composition comprising opioids Dec, 2027

(5 years from now)

US8470361 OREXO US INC Non-abusable pharmaceutical composition comprising opioids May, 2030

(7 years from now)

US11020388 OREXO US INC Abuse-resistant pharmaceutical composition for the treatment of opioid dependence Sep, 2032

(9 years from now)

US11020387 OREXO US INC Abuse-resistant pharmaceutical composition for the treatment of opioid dependence Sep, 2032

(9 years from now)

US10946010 OREXO US INC Abuse-resistant pharmaceutical composition for the treatment of opioid dependence Sep, 2032

(9 years from now)

US8940330 OREXO US INC Abuse-resistant pharmaceutical composition for the treatment of opioid dependence Sep, 2032

(9 years from now)

US9439900 OREXO US INC Abuse-resistant pharmaceutical composition for the treatment of opioid dependence Sep, 2032

(9 years from now)

US9259421 OREXO US INC Abuse-resistant pharmaceutical composition for the treatment of opioid dependence Sep, 2032

(9 years from now)

US10874661 OREXO US INC Abuse-resistant pharmaceutical composition for the treatment of opioid dependence Sep, 2032

(9 years from now)

Drugs and Companies using BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE ingredient

Treatment: Sublingual or buccal administration of a pharmaceutical composition comprising buprenorphine and naloxone; Sublingual administration of a pharmaceutical composition comprising buprenorphine and naloxone; Use of zubsolv for treatment of opioid dependence

Dosage: TABLET;SUBLINGUAL

More Information on Dosage
Strength Dosage Availability
EQ 0.7MG BASE;EQ 0.18MG BASE TABLET;SUBLINGUAL Prescription
EQ 1.4MG BASE;EQ 0.36MG BASE TABLET;SUBLINGUAL Prescription
EQ 2.9MG BASE;EQ 0.71MG BASE TABLET;SUBLINGUAL Prescription
EQ 5.7MG BASE;EQ 1.4MG BASE TABLET;SUBLINGUAL Prescription
EQ 8.6MG BASE;EQ 2.1MG BASE TABLET;SUBLINGUAL Prescription
EQ 11.4MG BASE;EQ 2.9MG BASE TABLET;SUBLINGUAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.